News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Filippo Montemurro: Uncovering Actionable Targets in GATA3-Mutant HR+ Resistant Tumors
Collage photo of Filippo Montemurro and Arielle J. Medford
Jul 6, 2025, 15:32

Filippo Montemurro: Uncovering Actionable Targets in GATA3-Mutant HR+ Resistant Tumors

Filippo Montemurro, Senior Medical Director at Roche, shared a post on X about a paper by Arielle J. Medford et al. published in Breast Cancer Research and Treatment:

“Conoccurring mutations in GATA3 mutant tumors may reveal actionable targets in HR+ resistant tumors. Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes – PubMed.”

Title: Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes

Authors: Arielle J. Medford, Marko Velimirovic, Yifat Gefen, Andrzej Niemierko, Lorenzo Gerratana, Andrew A. Davis, Katherine Clifton, Jennifer Keenan, Emily Podany, Whitney L. Hensing, Carolina Reduzzi, Charles S. Dai, Lesli A. Kiedrowski, Laura M. Spring, Leif W. Ellisen, Robert C. Doebele, Massimo Cristofanilli, Gad Getz, Aditya Bardia

You can read the Full Article in Breast Cancer Research and Treatment.

Filippo Montemurro: Uncovering Actionable Targets in GATA3-Mutant HR+ Resistant Tumors

More posts featuring Filippo Montemurro.

Aditya Bardia Andrzej Niemierko Arielle J. Medford Breast Cancer Breast Cancer Research and Treatment cancer Filippo Montemurro Gad Getz GATA3 Laura M. Spring Leif W. Ellisen Lorenzo Gerratana Marko Velimirovic Massimo Cristofanilli OncoDaily Oncology Robert C. Doebele Yifat Gefen
Special Coverage
Science
Jul 6, 2025, 15:32
Filippo Montemurro: Uncovering Actionable Targets in GATA3-Mutant HR+ Resistant Tumors
Science
Jul 6, 2025, 15:22
Rahul Banerjee: Off-the-Shelf In Vivo BCMA CAR-T in Myeloma Hits The Lancet
Insight
Jul 6, 2025, 15:11
PSOGI World News - Looking at Alternatives Intraperitoneal Treatments
Science
Jul 6, 2025, 15:03
From Evidence to Insight: KEYNOTE-689 Trial and Editorial on Harnessing Immunotherapy in Head and Neck Cancer
Oncolibrary
Jul 6, 2025, 14:44
Breast Cancer Success Rate: What Patients Should Know in 2025
Science
Jul 6, 2025, 13:48
Keith Siau: A Must-Read Overview of the Management of Oesophageal and Oropharyngeal Dysphagia
Blog
Jul 6, 2025, 13:43
Jordan Johnson: The Independence This Is Worth Fighting For
Blog
Jul 6, 2025, 13:35
Michael Dickinson: Discussions with APAC Haematologists at the Peter MacCallum Lymphoma Symposium
Insight
Jul 6, 2025, 13:24
E. Shyam P. Reddy: What Keeps Obese Mice Alive
Blog
Jul 6, 2025, 13:20
Together, We’re Turning Science Into Action, and Action Into Hope - European Liver Patients’​ Association
Blog
Jul 6, 2025, 13:16
Hedley Lewis: Gratitude for Supporting Children and Teens Undergoing Cancer Treatment
Science
Jul 6, 2025, 12:58
Myeloma Paper of the Day, July 6th, Suggested by Robert Orlowski